With NV, Jeunesse Global proves to be the envy of the cosmetics industry

When Randy Ray and Wendy Lewis founded Jeunesse Global out of their garage back in 2009, they weren’t immediately aiming for the stars. In fact, the inveterate entrepreneurs had just retired. But they quickly found that days filled with nothing to do and no deeper purpose were as stifling as the most stressful days at work. They decided to found yet another business as a way to simply pass the time.

Once they founded their company, however, the couple’s entrepreneurial instincts began to kick in. They soon found themselves spending 60-plus hours per week growing their fledgling company. Just one month after officially retiring, Ray and Lewis were back at work.

Over the course of the next five years, the direct-marketing gurus would grow their hobby business into a hundred-million-dollar company, a feat so astounding that it’s likely that a similar story has never been witnessed in the global health and beauty industry. The secret behind the unrelenting exponential growth has been the company’s rock-solid business plan and its highly effective and sought-after products.

One example of the transformative and innovative products that the company routinely creates is its NV foundation and bronzer. As a standalone foundation, NV can’t be beaten. Many first-time users are amazed at the evenness and vital, natural glow that it gives their skin. So convincing is the natural look of NV that a plurality of users decides to forgo makeup altogether. NV also comes in a wide range of hues, enabling it to be matched to whatever skin tone the user desires. This latter feature has made NV particularly popular among East Asians, who are able to use it as a mild skin lightener.

But where NV really struts its stuff is in the area of aging prevention and age reversal. Formulated with Jeunesse’s patented anti-aging molecule, APT-200, NV can instantly take years off of a consumer’s appearance. The astonishing ability of NV to wipe away years or even decades off a user’s apparent age is the real reason behind the incredible demand for this product.

https://bestcompany.com/mlm/company/jeunesse-global

Scott Rocklage 5AM Ventures RNA Disorder Management

Scott Rockladge one of the venture captilasits in charge of the group 5AM Ventures has started to make headway in new research aimed at creating a cure for various genetic disorders.

One of these disorders, Mytonic dystrophy type I is well known for being the leading cause of muscular dystrophy in adults. His company recently donated over 50 million dollars to fight this disease. Read more: Scott Rocklage | Crunchbase and Scott Rocklage | Bloomberg

Symptoms of this disease are thought to become present after RNA levels reach a toxic threshold amount. RNA is used to convert the messages inside of DNA into usable proteins by the cell. Typically these RNA molecules are then broken down afterwards and disposed of by the body. In some cases this does not occur and RNA levels build up to toxic amounts causing issues throughout the body.

Expansion Therapeutics has created medications that help treat diseases caused by RNA. Their primary focus is on a subset of these disorders called expansion repeat disorders. These are hereditary illnesses that do not respond to typical medical treatment. These are caused by tiny defective segments of DNA. Myotonic Dystrophy type I is one such disease.

Scott Rocklage recently released a press statement from Dr. Disney which held that now disease related RNA are capable of being targeted with small molecule medications.

This represents a breakthrough in the way these diseases are treated. It is believed they are nearing a point where actual applications will be possible to treat a previously unreachable segment of the population.

These medications depend on science that has the potential to treat RNA based illnesses. Meaning that these medications will be used to treat and even cure diseases that currently have no treatment options. Learn more about Scott Rocklage: https://www.linkedin.com/in/scott-rocklage-66aa7a12a and https://ideamensch.com/scott-rocklage/

5AM Ventures has had a hand in bankrolling these projects. Headed by Scott Rocklage who has over 3- years of experience in the healthcare management industry. He has been at the helm of three medications which have been approved by the FDA Cubicin Teslascan and Omniscan.

With over 100 peer reveiwed publications Scott Rocklage is more than just another businessman with money behind his words but rather an all-new breed of investor who utilizes not just capital but his knowledge of the industry to lead his investment decisions.